Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 7/20 | 0.77 |
| ▸ | CA2 | P00918 | 7/20 | 0.77 |
| ▸ | CA9 | Q16790 | 6/20 | 0.77 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.70 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | CTRC | Q99895 | 1/20 | 0.45 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.45 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.45 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.45 |
| ▸ | GFER | P55789 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.42 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL347721 | 0.94 | CA12 (0.68) | CA12CA2CA9KDM4ECA1 | |
| SCHEMBL347803 | 0.94 | CA12 (0.68) | CA12CA2CA9KDM4ECA1 | |
| SCHEMBL29610101 | 0.91 | CA12 (0.78) | CA12CA2CA9KDM4ECA1 | |
| SCHEMBL16221721 | 0.91 | CA12 (0.78) | CA12CA2CA9KDM4ECA1 | |
| SCHEMBL5350861 | 0.91 | CA12 (0.78) | CA12CA2CA9KDM4ECA1 | |
| SCHEMBL19209979 | 0.91 | CA12 (0.78) | CA12CA2CA9KDM4ECA1 | |
| SCHEMBL12996009 | 0.91 | CA12 (0.78) | CA12CA2CA9KDM4ECA1 | |
| SCHEMBL14674401 | 0.89 | CA12 (0.75) | CA12CA2CA9KDM4ECA1 | |
| SCHEMBL14674400 | 0.89 | CA12 (0.75) | CA12CA2CA9KDM4ECA1 | |
| SCHEMBL346868 | 0.89 | CA12 (0.65) | CA12CA2CA9KDM4ECA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2468801-B1 | PROCESS FOR PRODUCING THERMOPLASTIC RESIN COMPOSITION, MOLDED OBJECT, AND LUMINESCENT OBJECT | MITSUBISHI RAYON CO (JP) | 2017-04-26 | — | — | EP | disclosed |
| US-8889785-B2 | Production method of thermoplastic resin composition, molded body, and light emission body | MITSUBISHI RAYON CO., LTD. (JP) | 2014-11-18 | — | — | US | disclosed |
| US-20120214922-A1 | PRODUCTION METHOD OF THERMOPLASTIC RESIN COMPOSITION, MOLDED BODY, AND LIGHT EMISSION BODY | MITSUBISHI RAYON CO., LTD. (JP) | 2012-08-23 | — | — | US | disclosed |
| EP-2468801-A1 | PROCESS FOR PRODUCING THERMOPLASTIC RESIN COMPOSITION, MOLDED OBJECT, AND LUMINESCENT OBJECT | Mitsubishi Rayon Co., Ltd. (JP) | 2012-06-27 | — | — | EP | disclosed |
| US-6810575-B1 | COMPRISES SUBSTRATE HAVING ON UPPER SURFACE A PLURALITY OF METAL OXIDE NEEDLES EXTENDING UPWARDLY OF SURFACE WITH THEIR CENTRAL AXES PARALLEL WITH EACH OTHER; NEEDLES HAVE SPECIFIC AVERAGE CIRCLE-BASED DIAMETER, ASPECT RATIO; CAPACITOR | ASAHI KASAI CHEMICALS CORPORATION (JP) | 2004-11-02 | — | — | US | disclosed |
| EP-1116707-B1 | Process for producing ketoisophorone | DAICEL CHEM (JP) | 2003-04-23 | — | — | EP | disclosed |
| EP-0962440-B1 | Oxidation catalytic system and process for producing ketoisophorone using the same | DAICEL CHEM (JP) | 2002-11-13 | — | — | EP | disclosed |
| US-6462239-B2 | USING AN OXIDATION CATALYST COMPRISING A CRYSTALLINE COMPLEX OF MANGANESE WITH N,N'-DISALICYLIDENE C6-12 ARYLENEDIAMINES TO OXIDIZED A SUBSTRATE, E.G., BETA-ISOPHORONE TO AN OXIDE, E.G., KETOISOPHORONE, WITH HIGH EFFICIENCY AND SELECTIVITY | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2002-10-08 | — | — | US | disclosed |
| US-6410797-B1 | CATALYTIC OXIDATION | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2002-06-25 | — | — | US | disclosed |
| US-20020055657-A1 | Process and apparatus for producing ketoisophorone | DAICEL CHEMICAL INDUSTRIES,LTD. | 2002-05-09 | — | — | US | disclosed |
| US-6346651-B1 | OXIDATION OF BETA-ISOPHORONE WITH CATALYST, SEPARATION FROM SOLVENT, CIRCULATION AND PURIFICATION | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2002-02-12 | — | — | US | disclosed |
| US-20020007098-A1 | Oxidation catalyst and oxidation process using the same | DAICEL CHEMICAL INDUSTRIES, LTD. | 2002-01-17 | — | — | US | disclosed |
| EP-1116707-A1 | Process and apparatus for producing ketoisophorone | Daicel Chemical Industries, Ltd. (JP) | 2001-07-18 | — | — | EP | disclosed |
| US-6255509-B1 | Oxidation catalyst and oxidation process using the same | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2001-07-03 | — | — | US | disclosed |
| EP-1067107-A1 | PROCESS FOR THE PRODUCTION OF KETOISOPHORONE DERIVATIVES AND EQUIPMENT THEREFOR | Daicel Chemical Industries, Ltd. (JP) | 2001-01-10 | — | — | EP | disclosed |
| US-6166261-A | Oxidation catalytic system and process for producing ketoisophorone using the same | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2000-12-26 | — | — | US | disclosed |
| EP-0962252-A2 | Manganese complex oxidation catalyst and use thereof | Daicel Chemical Industries, Ltd. (JP) | 1999-12-08 | — | — | EP | disclosed |
| EP-0962440-A1 | Oxidation catalytic system and process for producing ketoisophorone using the same | Daicel Chemical Industries, Ltd. (JP) | 1999-12-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020055657-A1 | Process and apparatus for producing ketoisophorone | DHCR7, KMO, AKR1B10 | CA12 851/4885CA2 533/4885CA9 310/4885 |
| US-20020007098-A1 | Oxidation catalyst and oxidation process using the same | CYP11B2, HSD17B7, CYP11B1 | CA12 431/4885CA2 618/4885CA9 548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.